InvestorsHub Logo
icon url

Frustrated

06/13/13 3:23 PM

#127598 RE: jakedogman1 #127597

Jake, I think you are being a little harsh on the BOD. After all remember they did an exhaustive search for a qualified COB and did numerous interviews and background checks and they came up with the prestigious Carlton Johnson. Don't get down because Carlton said he was going to get to the bottom of this. I believe that was 9 months ago and counting. All imo.
icon url

dia76ca

06/13/13 3:56 PM

#127605 RE: jakedogman1 #127597

The company has great management...that is why they have made great progress in the past 4 years. King and Garnick are very able honest men. Some drug combinations are better than others. Some cancer indications are tougher than others. But biopharms point about Bavi playing well with others is important. This means it works well with most current SOC and will work well with the coming generation of drugs. I can see Bavi being used with combination treatments in lung, breast, pancreatic, liver....indeed with ALL solid tumours...and with the new generation of immunotherapeutic drugs and vaccines. And we are very near the use of second generation BAVI. And all because of the great science of Dr. Thorpe and the great management of King and Garnick. Things are going well...the share price will follow!
icon url

BCS Paladin

06/13/13 5:38 PM

#127616 RE: jakedogman1 #127597

OUR BOD IS JUST DANDY

Of bunch of outsiders would sell out for $15 and
spend the rest of their lives bragging about how
great they were.